Wei-Wu He - Jun 16, 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
He Wei-Wu
Reporting Manager
WEI-WU HE, Ph.D.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
15.7M shares
Disclosed Ownership
3.74M shares
Ownership
23.8%
Form type
SCHEDULE 13D/A
Date filed
6/20/2025, 04:30 PM
Date of event
Jun 16, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 23.8% 3.74M 2.13M 1.6M /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 2.6% 408K 0 408K /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 7.1% 1.1M 0 1.1M /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 4.9% 753K 0 753K EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND , L.P. 1.9% 300K 0 300K EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.6% 100K 0 100K /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee